| 产品描述: | Exicorilant (CORT 125281) is a selective and oral active glucocorticoid receptor (GR) antagonist, with a Ki value of 7 nM. Exicorilant (CORT 125281) has potential to overcome adiposity, glucose intolerance and dyslipidaemia. |
| 体外研究: |
Exicorilant (CORT 125281) 可降低 HFD 喂养小鼠的体重、脂肪量和血脂[2]。 Exicorilant (CORT 125281) (6、20 或 60 mg/kg/d,在小鼠中持续 3 周) 以剂量依赖的方式降低体重、脂肪量、血浆甘油三酯、胆固醇和游离脂肪酸,对瘦体重没有影响[2]。 |
| 体内研究: |
Exicorilant (CORT 125281) 在体外逆转小鼠棕色脂肪细胞中皮质酮介导的 GR 活性。 |
| 参考文献: |
1. Hunt HJ, et al. Identification of the Clinical Candidate (R)-(1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A Selective Glucocorticoid Receptor (GR) Antagonist. J Med Chem. 2017 Apr 27;60(8):3405-3421. 2. Kroon J, et al. Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice. Endocrinology. 2018 Jan 1;159(1):535-546. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.696 ml |
8.481 ml |
16.962 ml |
| 5 mM |
0.339 ml |
1.696 ml |
3.392 ml |
| 10 mM |
0.17 ml |
0.848 ml |
1.696 ml |
| 50 mM |
0.034 ml |
0.17 ml |
0.339 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |